Visit Us at Booth 5

Precision in Drug Discovery & Preclinical Summit

June 10—11, 2024 | Boston, MA

We’re exhibiting at the 23rd Precision in Drug Discovery & Preclinical Summit (PDDP) in Boston happening June 10-11 at booth 5. Join us for a two-day exploration of innovation in the drug discovery industry, connecting with experts and gaining insights to advance scientific strategies. We’re looking forward to the opportunity to network, collaborate, and drive groundbreaking discoveries with you and hope to see you at the conference.

Noble’s scientists can manage your drug development programs through each phase of the preclinical process, from design and implementation to regulatory support of your IND, IDE or PMA FDA submission.We are proud to be your partner to support your research efforts in the field of drug development, and lead you through each critical process during this transformative journey towards bringing revolutionary advancements to patients worldwide.

Click here to pre-book a meeting time with us, or stop by booth 5 to meet with Srujana Cherukuri, Ph.D or Yongping Chen, M.D., Ph.D. to discuss the latest developments in preclinical research at Noble Life Sciences.

We look forward to meeting you in Boston!

Learn More About Noble’s CRO Services:

Mouse models

  • Syngeneic Tumor Models
  • Orthotopic, Metastasis/Disseminated Xenograft Models
  • Humanized Mouse Models
  • Patient-derived Xenograft Models (PDX)
  • Cell Line-derived Xenograft Models (CDX)


  • IVIS Optical Live Animal Imaging
  • Fluoroscopy Imaging System
  • Radiology
  • Ultrasound

In Vitro Assays

  • Expansion and Activation of CAR-T Cells (Proliferation, Activation, Cytolytic Activity & Cytokine Production of CAR-T Cells)
  • Flexibility to Build Out T-cell Production Capabilities
  • Flow Cytometry-Based Assays to Support Immuno-oncology Drug Development
  • Cytotoxicity and Immunotoxicity Assays
  • PK/PD and Efficacy Studies
  • Flow and PCR-based Biodistribution Assays
  • Cellular Activation and Stimulation Assays
  • Human Whole Blood Stimulation Assays

Meet the Noble Attendees

See Us at Booth 5

Srujana Cherukuri, Ph.D

Chief Executive Officer

Janet Olugbodi

Yongping Chen, M.D., Ph.D.

Senior Study Director

Noble Life Sciences, is a global preclinical CRO dedicated to innovation and scientific discovery. With a proven track record in navigating the complexities of preclinical research, our dedicated team is poised to be your strategic partner in advancing your scientific initiatives, including drug and vaccine development.

The Precision in Drug Discovery & Preclinical Event will be a unique platform for the largest bio-pharmaceutical hub in the region to network and discuss collaboration in order to achieve their discovery and scientific strategies.

Visit Us at Booth 5

Precision in Drug Discovery & Preclinical Summit

June 10-11, 2024 | Hilton Boston Park Plaza, Boston, MA